Research into psilocybin’s promise as a mental health treatment is expanding beyond mood disorders. In a new study, researchers found that participants consumed the psychedelic substance in a ...

Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater ...

Newly published research on the psychiatric effects of psilocybin suggests a complicated, potentially bidirectional relationship between the psychedelic’s therapeutic effects and sleep. Taking ...

Psilocybin vs the control was consistently more effective in improving anxiety symptoms in 80% of the evaluated randomized controlled trials. Psilocybin may offer a treatment option for major ...

Psilocybin-assisted therapy, which involves using the active ingredient from "magic mushrooms," could benefit roughly 5 million people currently receiving treatment for major depressive disorder and ...

Philomath will continue banning psilocybin manufacturers and service centers for at least the next two years, following a City Council vote last month. The city's existing ban was set to expire ...

Oregon’s first psilocybin service centers opened around a year ago, providing psychedelic mushrooms to treat conditions like PTSD. One center in Southern Oregon is trying to increase access with ...

The drugs are very harmful and they need to be given under medical supervision. We're in *** mental health crisis and the options we currently have just aren't serving people the way we need to ...

A small double-blind randomized clinical trial of US frontline healthcare workers with COVID-19 pandemic–related depression finds that the psychedelic drug psilocybin can relieve feelings of despair ...